Screener
Kiniksa Pharmaceuticals International, plc KNSA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on the most recent quarter.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's debt-to-equity?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported debt-to-equity of 0× in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's debt-to-equity changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's debt-to-equity decreased by 31.0% year-over-year, from 0× to 0×.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's debt-to-equity?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's debt-to-equity has grown at a -5.7% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Kiniksa Pharmaceuticals International, plc's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude